Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2025-12-30 @ 12:45 PM
Study NCT ID:
NCT04872634
Status:
UNKNOWN
Last Update Posted:
2021-07-21
First Post:
2021-04-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment
Sponsor:
NKMAX Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-08
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-26
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-05-26
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-21
First Submit QC Date:
None
Study First Post Date:
2021-05-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-15
Last Update Post Date:
2021-07-21
Last Update Post Date Type:
ACTUAL